Interference with vital cellular signaling pathways (e.g., Wnt/β-catenin, Notch, STAT3, mTOR, or NF-κB) was also documented for niclosamide and structurally related salicylanilides in various cancers [5,6]. The gene discussed is STAT3; the disease is cancer.